Abstract
Interference with the innate apoptotic activity is a hallmark of neoplastic transformation and tumor formation. Modulation of the apoptotic cascade has been proposed as a new approach for the treatment of cancer. In this chapter, we discuss the role of apoptosis in ovarian cancer and the use of phenoxodiol as a model for the regulation of apoptosis and potential use as chemosensitizer for chemoresistant ovarian cancer cells.
MeSH terms
-
Animals
-
Antineoplastic Agents / pharmacology
-
Antineoplastic Agents / therapeutic use
-
Apoptosis / drug effects
-
Apoptosis / genetics*
-
Apoptosis / physiology*
-
Chemotherapy, Adjuvant
-
Drug Resistance, Neoplasm* / drug effects
-
Drug Resistance, Neoplasm* / genetics
-
Gene Expression Regulation, Neoplastic
-
Humans
-
Inhibitor of Apoptosis Proteins / physiology
-
Isoflavones / pharmacology
-
Isoflavones / therapeutic use
-
Models, Biological
-
Neoplasms / drug therapy
-
X-Linked Inhibitor of Apoptosis Protein / genetics
Substances
-
Antineoplastic Agents
-
Inhibitor of Apoptosis Proteins
-
Isoflavones
-
X-Linked Inhibitor of Apoptosis Protein
-
phenoxodiol